CEBP http://www.cancermicroenvironment.tau.ac.il/welcome2009.html Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 1009, May 1, 2007. doi: 10.1158/1055-9965.EPI-06-0899
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Low, Y.-L.
Right arrow Articles by Bingham, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Low, Y.-L.
Right arrow Articles by Bingham, S. A.
Related Collections
Right arrow Oncogenesis
Right arrow Oncogenesis: Biomarkers

Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants

Yen-Ling Low1, Alison M. Dunning2, Mitch Dowsett3, Elizabeth Folkerd3, Deborah Doody3, James Taylor1, Amit Bhaniani4, Robert Luben4, Kay-Tee Khaw4, Nick J. Wareham4 and Sheila A. Bingham1,4

1 Medical Research Council Dunn Human Nutrition Unit; 2 Cancer Research-UK Department of Oncology, Strangeways Research Laboratory; 3 Institute of Cancer Research, London, United Kingdom; and 4 European Prospective Investigation of Cancer and Nutrition-Norfolk, Strangeways Research Laboratory, Cambridge, United Kingdom

Requests for reprints: Sheila A. Bingham, Medical Research Council Dunn Human Nutrition Unit, Wellcome Trust/Medical Research Council Dunn Human Nutrition Unit Building, Hills Road, Cambridge CB2 2XY, United Kingdom. Phone: 44-1223-252760; Fax: 44-1223-252765. E-mail: sab{at}mrc-dunn.cam.ac.uk

In this large cross-sectional study, we investigated the relationship between phytoestrogen exposure and circulating sex hormones and sex hormone-binding globulin (SHBG) levels in 1988 healthy postmenopausal women and their interactions with polymorphisms in genes involved in estrogen signaling. Plasma estradiol, testosterone, androstenedione, estrone, and SHBG were measured. Urinary levels of five isoflavones (daidzein, genistein, glycitein, O-desmethylangolensin, and equol) and two lignans (enterodiol and enterolactone) were measured and used as biomarkers for dietary intakes. Eighteen polymorphisms in ESR1, ESR2, and NR1I2 genes were genotyped. Results showed that lignans were positively associated with plasma SHBG levels ({eta}p2 = 1.2%; P < 0.001) and negatively associated with plasma testosterone ({eta}p2 = 0.2%; P = 0.042). Equol was negatively associated with plasma estradiol levels ({eta}p2 = 0.3%; P = 0.028), whereas O-desmethylangolensin was positively associated with plasma estradiol level ({eta}p2 = 0.3%; P = 0.010). There were significant phytoestrogen interactions with polymorphisms in ESR1 and NR1I2 genes in affecting estrone levels. We conclude that phytoestrogens modulate sex hormone and SHBG levels in postmenopausal women and interact with gene variants involved in estrogen signaling. Such phytoestrogen-gene interactions may explain the conflicting literature on the hormonal effects of phytoestrogens. (Cancer Epidemiol Biomarkers Prev 2007;16(5):1009–16)




This article has been cited by other articles:


Home page
J. Nutr.Home page
E. Sonestedt, M. I. L. Ivarsson, S. Harlid, U. Ericson, B. Gullberg, J. Carlson, H. Olsson, H. Adlercreutz, and E. Wirfalt
The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor {alpha} and {beta} Genes
J. Nutr., May 1, 2009; 139(5): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Pan, O. H. Franco, J. Ye, W. Demark-Wahnefried, X. Ye, Z. Yu, H. Li, and X. Lin
Soy Protein Intake Has Sex-Specific Effects on the Risk of Metabolic Syndrome in Middle-Aged and Elderly Chinese
J. Nutr., December 1, 2008; 138(12): 2413 - 2421.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, H. Olsson, H. Adlercreutz, G. Landberg, and E. Wirfalt
Enterolactone Is Differently Associated with Estrogen Receptor {beta}-Negative and -Positive Breast Cancer in a Swedish Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3241 - 3251.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Hedelin, M. Lof, M. Olsson, H. Adlercreutz, S. Sandin, and E. Weiderpass
Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women
J. Nutr., May 1, 2008; 138(5): 938 - 945.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.